Cargando…

1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosis

Foxp3(+) regulatory T (T(reg)) cells contribute to the local dysfunctional immune environment in endometriosis, an estrogen-dependent gynecological disease, which affects the function of ectopic endometrial tissue clearance by the immune system. The reason for the high percentage of peritoneal T(reg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Chunyan, Mei, Jie, Tang, Lingli, Liu, Yukai, Li, Dajin, Li, Mingqing, Zhu, Xiaoyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260991/ https://www.ncbi.nlm.nih.gov/pubmed/27906184 http://dx.doi.org/10.1038/cddis.2016.375

Ejemplares similares

Tryptophan Feeding of the IDO1-AhR Axis in Host–Microbial Symbiosis
por: Zelante, Teresa, et al.
Publicado: (2014)

IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan
por: Metz, Richard, et al.
Publicado: (2012)

The Extracellular Vesicle–Macrophage Regulatory Axis: A Novel Pathogenesis for Endometriosis
por: Gao, Xiaoxiao, et al.
Publicado: (2023)

The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
por: Opitz, Christiane A., et al.
Publicado: (2011)

Heme-binding-mediated negative regulation of the tryptophan metabolic enzyme indoleamine 2,3-dioxygenase 1 (IDO1) by IDO2
por: Lee, Young-Kwan, et al.
Publicado: (2014)

USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer
por: Shi, Dongni, et al.
Publicado: (2022)

Design, synthesis and evaluation of tryptophan analogues as tool compounds to study IDO1 activity
por: Cundy, Nicholas J., et al.
Publicado: (2021)

IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease
por: Sucher, Robert, et al.
Publicado: (2010)

Peritoneal immune microenvironment of endometriosis: Role and therapeutic perspectives
por: Chen, Siman, et al.
Publicado: (2023)

IL4i1 and IDO1: Oxidases that control a tryptophan metabolic nexus in cancer
por: Zeitler, Leonie, et al.
Publicado: (2023)

Psychological Stress-Induced, IDO1-Dependent Tryptophan Catabolism: Implications on Immunosuppression in Mice and Humans
por: Kiank, Cornelia, et al.
Publicado: (2010)

Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO
por: Kim, Minah, et al.
Publicado: (2021)

IDO-induced immunosuppressive tryptophan catabolism following primary HIV infection
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

The IDO inhibitor 1-methyl tryptophan activates the aryl hydrocarbon receptor response in mesenchymal stromal cells
por: Lewis, Holly C., et al.
Publicado: (2017)

Role of miR-449b-3p in endometriosis via effects on endometrial stromal cell proliferation and angiogenesis
por: Liu, Yukai, et al.
Publicado: (2018)

Limitations and Off-Target Effects of Tryptophan-Related IDO Inhibitors in Cancer Treatment
por: Günther, Juliane, et al.
Publicado: (2019)

Activities of plasma indoleamine-2, 3-dioxygenase (IDO) enzyme in Nigerian patients with lung diseases: basis for tryptophan supplementation or IDO inhibitor use
por: Arinola, Ganiyu Olatunbosun, et al.
Publicado: (2023)

The Coevolution of IDO1 and AhR in the Emergence of Regulatory T-Cells in Mammals
por: Grohmann, Ursula, et al.
Publicado: (2015)

Tryptophan-kynurenine pathway attenuates β-catenin-dependent pro-parasitic role of STING-TICAM2-IRF3-IDO1 signalosome in Toxoplasma gondii infection
por: Majumdar, Tanmay, et al.
Publicado: (2019)

Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate cells
por: Newman, Alice Clare, et al.
Publicado: (2021)

Estrogen Receptors and Endometriosis
por: Chantalat, Elodie, et al.
Publicado: (2020)

Impact of IDO1 and IDO2 on the B Cell Immune Response
por: Merlo, Lauren M. F., et al.
Publicado: (2022)

Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma
por: Zhai, Lijie, et al.
Publicado: (2021)

MRC2020: improvements to Ximdisp and the MRC image-processing programs
por: Short, J. M., et al.
Publicado: (2023)

Tryptophan Metabolism and Gut Microbiota: A Novel Regulatory Axis Integrating the Microbiome, Immunity, and Cancer
por: Hou, Yingjian, et al.
Publicado: (2023)

Host cell depletion of tryptophan by IFNγ-induced Indoleamine 2,3-dioxygenase 1 (IDO1) inhibits lysosomal replication of Coxiella burnetii
por: Ganesan, Sandhya, et al.
Publicado: (2019)

Amyloid β neurotoxicity is IDO1–Kyn–AhR dependent and blocked by IDO1 inhibitor
por: Duan, Zhenzhen, et al.
Publicado: (2020)

Cang-Ai Volatile Oil Ameliorates Depressive Behavior Induced by Chronic Stress Through IDO-Mediated Tryptophan Degradation Pathway
por: Zhang, Kailing, et al.
Publicado: (2021)

Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses
por: Merlo, Lauren M. F., et al.
Publicado: (2020)

Bidirectional regulation between 1st trimester HTR8/SVneo trophoblast cells and in vitro differentiated Th17/Treg cells suggest a fetal‐maternal regulatory loop in human pregnancy
por: Wang, Songcun, et al.
Publicado: (2019)

MRC2014: Extensions to the MRC format header for electron cryo-microscopy and tomography
por: Cheng, Anchi, et al.
Publicado: (2015)

Association of breast carcinoma growth with a non-canonical axis of IFNγ/IDO1/TSP1
por: Lopes-Bastos, Bruno, et al.
Publicado: (2017)

Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening
por: Sari, Suat, et al.
Publicado: (2019)

Electroacupuncture Relieves LPS-Induced Depression-Like Behaviour in Rats Through IDO-Mediated Tryptophan-Degrading Pathway
por: Zhang, Kun, et al.
Publicado: (2020)

ERRFI1 induces apoptosis of hepatocellular carcinoma cells in response to tryptophan deficiency
por: Cui, Mingqing, et al.
Publicado: (2021)

IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype
por: Lee, Alexander, et al.
Publicado: (2014)

Targeting the STAT5A/IDO1 axis overcomes radioresistance and reverses the immunosuppressive tumor microenvironment in NSCLC
por: Yang, Yang, et al.
Publicado: (2022)

Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans
por: Napolioni, Valerio, et al.
Publicado: (2019)

Prognostic value of the PrP(C)-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype
por: Ghazi, Alexandre, et al.
Publicado: (2021)

Chronic Treatment with the IDO1 Inhibitor 1-Methyl-D-Tryptophan Minimizes the Behavioural and Biochemical Abnormalities Induced by Unpredictable Chronic Mild Stress in Mice - Comparison with Fluoxetine
por: Laugeray, Anthony, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k0th167b5qecq85a5b4ouo6sum